| Click and Release: SO2 Prodrugs with Tunable Release Rates X Ji, EM El-Labbad, K Ji, DS Lasheen, RAT Serya, KA Abouzid, B Wang Organic letters 19 (4), 818-821, 2017 | 38 | 2017 |
| A New Xanthone Glycoside from Mangifera indica L.: Physicochemical Properties and In Vitro Anti-Skin Aging Activities HAS El-Nashar, EM El-Labbad, MA Al-Azzawi, NS Ashmawy Molecules 27 (9), 2609, 2022 | 31 | 2022 |
| Discovery of Novel Peptidomimetics as Irreversible CHIKV Ns P 2 Protease Inhibitors Using Quantum Mechanical‐Based Ligand Descriptors EM El‐labbad, MAH Ismail, DA Abou Ei Ella, M Ahmed, F Wang, ... Chemical Biology & Drug Design 86 (6), 1518-1527, 2015 | 28 | 2015 |
| Identification of a promising hit from a new series of pyrazolo [1, 5-a] pyrimidine based compounds as a potential anticancer agent with potent CDK1 inhibitory and pro … HR Elgiushy, SH Mohamed, H Taha, H Sawaf, Z Hassan, NA Abou-Taleb, ... Bioorganic Chemistry 120, 105646, 2022 | 13 | 2022 |
| Novel Secreted Peptides From Rhizopus arrhizus var. delemar With Immunomodulatory Effects That Enhance Fungal Pathogenesis SSM Soliman, EM El-Labbad, A Abu-Qiyas, B Fayed, AM Hamoda, ... Frontiers in Microbiology 13, 863133, 2022 | 10 | 2022 |
| The Anti-Candida Activity of Tephrosia apollinea Is More Superiorly Attributed to a Novel Steroidal Compound with Selective Targeting NS Ashmawy, EM El-Labbad, AM Hamoda, AA El-Keblawy, ... Plants 11 (16), 2120, 2022 | 9 | 2022 |
| Medicinal chemistry strategies towards SO2 donors as research tools and potential therapeutics EM El-Labbad, X Ji, KAM Abouzid, B Wang Current Topics in Medicinal Chemistry 21 (32), 2870-2881, 2021 | 7 | 2021 |
| Bioactive marine metabolites derived from the Persian Gulf compared to the Red Sea: Similar environments and wide gap in drug discovery RK Abuhijjleh, S Shabbir, AM Al-Abd, NH Jiaan, S Alshamil, ... PeerJ 9, e11778, 2021 | 5 | 2021 |
| Investigation of waste electrical power plant oil as a rejuvenating agent for reclaimed asphalt binders and mixtures EM El-Labbad, U Heneash, SM El-Badawy Materials 15 (14), 4811, 2022 | 4 | 2022 |
| Novel sulfonamide-tethered Schiff bases as anti-proliferative agents with VEGFR-2 inhibitory activity: Synthesis, biological assessment, and molecular dynamic simulations MA Shaldam, MH Abdulla, A Angeli, SM Hefny, EM El-labbad, AB Obeed, ... Journal of Molecular Structure 1309, 138148, 2024 | 3 | 2024 |
| Virtual patient simulation in pharmacy education: A systematic review SA Beshir, AP Mohamed, A Soorya, SSL Goh, EM El-Labadd, N Hussain, ... International Pharmaceutical Federation, 2022 | 3 | 2022 |
| Development of certain benzylidene coumarin derivatives as anti-prostate cancer agents targeting EGFR and PI3Kβ kinases LMA Abdel Ghany, TS Ibrahim, AS Alharbi, MS Abdel-Aziz, EM El-labbad, ... Journal of Enzyme Inhibition and Medicinal Chemistry 39 (1), 2311157, 2024 | 2 | 2024 |
| Artificial Intelligence and Discovery of Microbial Natural Products R Hamdy, AM Altaie, EM El-Labbad, NS Ashmawy, DU Ozsahin, ... Drug Discovery and Design Using Natural Products, 37-78, 2023 | | 2023 |
| Statistical optimization of stable Quercetin nanoparticles for tumor targeting NK Hassan, E El-labbad, J jagal, M Haider, I El-sayed Cancer Research 83 (7_Supplement), 824-824, 2023 | | 2023 |
| In Silico Fragment-Based Drug Design and Molecular Docking of Tranilast Analogues as Potential Inhibitors of Transforming Growth Factor- β Receptor Type 1 NA Babiker, AT Negmeldin, EM El-Labbad Medical Sciences Forum 14 (1), 75, 2022 | | 2022 |
| School Poster Abstracts Presented at the 123rd Annual Meeting of the American Association of Colleges of Pharmacy, July 23-27, 2022 American Association of Colleges of Pharmacy American Journal of Pharmaceutical Education 86 (5), 2022 | | 2022 |
| Investigation of Waste Electrical Power Plant Oil as a Rejuvenating Agent for Reclaimed Asphalt Binders and Mixtures. Materials 2022, 15, 4811 EM El-labbad, U Heneash, SM El-Badawy s Note: MDPI stays neutral with regard to jurisdictional claims in published …, 2022 | | 2022 |
| Design and synthesis of imidazole derivatives as augmented prooxidant anticancer agents ASM Omar, EM El-Labbad, AM Al-Abd Cancer Research 81 (13_Supplement), 287-287, 2021 | | 2021 |
